These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28762762)

  • 1. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.
    Skau E; Henriksen E; Wagner P; Hedberg P; Siegbahn A; Leppert J
    Eur J Prev Cardiol; 2017 Oct; 24(15):1576-1583. PubMed ID: 28762762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P
    Am J Cardiol; 2011 Oct; 108(7):955-8. PubMed ID: 21784389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute-phase dynamics and prognostic value of growth differentiation factor-15 in ST-elevation myocardial infarction.
    Rueda F; Lupón J; García-García C; Cediel G; Aranda Nevado MC; Serra Gregori J; Labata C; Oliveras T; Ferrer M; de Diego O; Serra J; Revuelta López E; Bayés-Genís A
    Clin Chem Lab Med; 2019 Jun; 57(7):1093-1101. PubMed ID: 30707681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-differentiation factor-15 and major cardiac events.
    Lin JF; Wu S; Hsu SY; Yeh KH; Chou HH; Cheng ST; Wu TY; Hsu WT; Yang CC; Ko YL
    Am J Med Sci; 2014 Apr; 347(4):305-11. PubMed ID: 24521768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of ten-year event-free survival in patients with acute myocardial infarction (from the Adria, Bassano, Conegliano, and Padova Hospitals [ABC] study on myocardial infarction).
    Berton G; Cordiano R; Cavuto F; Giacomini G; De Toni R; Palatini P
    Am J Cardiol; 2012 Apr; 109(7):966-75. PubMed ID: 22221943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
    Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R
    Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
    Ritsinger V; Brismar K; Malmberg K; Mellbin L; Näsman P; Rydén L; Söderberg S; Tenerz Å; Norhammar A
    Diab Vasc Dis Res; 2017 Mar; 14(2):77-87. PubMed ID: 28185529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
    Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study.
    Farhan S; Freynhofer MK; Brozovic I; Bruno V; Vogel B; Tentzeris I; Baumgartner-Parzer S; Huber K; Kautzky-Willer A
    Cardiovasc Diabetol; 2016 Apr; 15():60. PubMed ID: 27056183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Inflammatory Biomarkers in Outpatients With Prior Myocardial Infarction.
    Minamisawa M; Motoki H; Izawa A; Kashima Y; Hioki H; Abe N; Miura T; Ebisawa S; Miyashita Y; Koyama J; Ikeda U
    Int Heart J; 2016; 57(1):11-7. PubMed ID: 26742699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
    Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatraemia on admission to hospital is associated with increased long-term risk of mortality in survivors of myocardial infarction.
    Burkhardt K; Kirchberger I; Heier M; Zirngibl A; Kling E; von Scheidt W; Kuch B; Meisinger C
    Eur J Prev Cardiol; 2015 Nov; 22(11):1419-26. PubMed ID: 25389071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
    Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
    Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohort.
    Ritsinger V; Brismar K; Mellbin L; Näsman P; Rydén L; Söderberg S; Norhammar A
    Diab Vasc Dis Res; 2018 Sep; 15(5):387-395. PubMed ID: 29992830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes.
    Omland T; Persson A; Ng L; O'Brien R; Karlsson T; Herlitz J; Hartford M; Caidahl K
    Circulation; 2002 Dec; 106(23):2913-8. PubMed ID: 12460871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction.
    Edfors R; Lindhagen L; Spaak J; Evans M; Andell P; Baron T; Mörtberg J; Rezeli M; Salzinger B; Lundman P; Szummer K; Tornvall P; Wallén HN; Jacobson SH; Kahan T; Marko-Varga G; Erlinge D; James S; Lindahl B; Jernberg T
    J Intern Med; 2020 Nov; 288(5):581-592. PubMed ID: 32638487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multibiomarker analysis in patients with acute myocardial infarction.
    Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
    Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.